GeistHaus
log in · sign up
39 pages link to this URL
The race between the bull and the bear: U.S. biopharma outlook in 2026 - Plenge Gen @rplenge

Introduction I just got back from the annual J.P. Morgan (JPM) Healthcare Conference, which got me thinking about the tension between optimism and pessimism in our industry. That reminded me of a surprising insight from Andrew Ross Sorkin’s 1929: Inside the Greatest Crash in Wall Street History: even days before the market collapsed, strong optimists (bulls) and pessimists (bears) were making their case for the U.S. economy. Today, biopharma faces a similar dynamic, raising an important question: what are the bull vs. bear arguments for 2026? And what events could tip the balance? In my view, there are four areas of U.S. biopharma to watch in 2026: scientific innovation, capital markets, China, and policy. For each, it’s a fascinating race between bull and bear arguments. Given my perch, I will spend this blog digging into the first three categories, as I am not a policy expert! But first, let’s discuss the overarching bull and bear cases in 2026. What are the bull and bear arguments for U.S. biopharma in 2026? I read Sorkin’s book at the end of 2025, while visiting my family for the holidays, which is why it was top of mind going into JPM. In the midst of reading the book, I reached out to colleagues and friends in biopharma for their perspective on bull vs. bear arguments in 2026. I also read published reports (here, here, here, here, here, here, here; my AI summary of analyst reports here) and re-watched Bruce Booth’s outstanding Year in Review (2025 video link here). I pressured tested my ideas during JPM and asked for input via LinkedIn. Those conversations and reports informed the perspective I share below – and what events to watch as the year unfolds. The bull argument starts with unmet medical need. Just look around – there […]

0 inbound links article en Drug Discovery artificial intelligenceassay developmentbiomarkercausal human biologyCellcholesterolclinical trialCRISPR-cas9cystic fibrosisdrug developmentepigeneticsgene therapygeneticsGWASimmunogenomicsindustryinnovationJAMAloss-of-function mutationsmatching modality and mechanismmechanism of action (MOA)mendelian randomizationMerckNatureNature GeneticsNature Review Drug DiscoveryNew England Journal of Medicinenext-generation sequencingParkinsons diseasepath to clinical PoCPCSK9personalized medicinepharmacogenomicsphenotypePheWASPokerpolygenicprecision medicineprogrammable therapeuticsrare variantsrheumatoid arthritisScience magazineScience Translational Medicinetarget validationTYK2
AI Scams Are the Point

Propaganda and deceit are a feature of AI, not its downfall.

4 inbound links article en MagazineDecember 2024CultureBooks & The ArtsBooksArtificial IntelligenceSnake OilChatgpt
Code Zen

I write pretty software

0 inbound links website en UncategorizedWorkRetrospectiveComcastWeb3AIThings-I-read financetechnology
wingolog

wingolog: article: tree-shaking, the horticulturally misguided algorithm

2 inbound links en schemeguilehootwasmwebassemblydcetree-shakinggcgarbage collectionpythongoclojureclojurescriptcompilersigalia
Why You Should NOT Become An AI Expert - Digital Tonto

There’s no doubt that artificial intelligence is a transformative technology, but so were smartphones, broadband mobile internet, cloud computing, and many other things over the last 20 years. It is truly amazing to think that just 20 years ago none of it existed and life was significantly different. Yet still, none of those things had and outsized impact on productivity. The most likely scenario is that the future will look a lot like the past. Many things will be improved, some will be transformed, but adoption will be uneven, with some organizations and industries moving quickly to put new applications into practice, while most will lag behind. As progress fails to meet expectations, disappointment and disillusionment will set in, and focus and budgets will shift elsewhere. If you are truly an AI expert, with the knowledge and skill to shape the technology, you can still expect to do well. There will never be a shortage of organizations that need people to help leverage technology to do important work for them. But if you are just chasing the wave, you will be tying yourself to the ebbs and flows of market sentiment. The truth is that you can’t separate a technology from the environment in which it operates. As the philosopher Martin Heidegger argued, to build for the world you need to understand what it means to live in it. Technology becomes powerful when people who understand solutions learn to collaborate effectively with those who understand the problems that need to be solved. So while there is clearly a need for genuine AI experts, we still need experts in every other human domain. You’re much better off betting on yourself than betting on a technology you have little or no agency over.

0 inbound links article en All Posts all posts
Generative AI and Main Character Syndrome Fatigue - Hit Subscribe

Yesterday I was wasting a little time on LinkedIn between calls. I ran across this post by April Dunford which resonated heavily with me and introduced me to a term I’d not previously heard: main character energy (or syndrome, I guess). I rolled up my sleeves and waded into the comments as a thought-follower, offering…

1 inbound link article en Content Marketing
Tuning out the AI bro snakeoil - how to use LLMs and stay sane

So this is an article I originally wrote last year for our agency’s internal knowledge base. It’s primarily aimed at junior devs, and I thought I’d share it on my public blog for others to peruse. To be clear, I use LLMs daily for work and play, whether that’s within Neovim or Zed, locally run Ollama models, or ChatGTP/Gemini web interfaces, so I’m hardly an anti-LLM naysayer. But it’s definitely a breathlessly over-hyped sector.

0 inbound links article en posts blogdevelopercode
AGI And The Trough of Disillusionment!

...And now for a new blog straight from HOPE 16 in Queens, NY! You would think that after a FULL day of talks, workshops and general hackery, I...

0 inbound links en CC BY-NC-SA 4.0
The Hype is the Product

Large publicly traded tech companies seem to no longer consider their customers – that is, people and organizations who actually buy their products or pay for access to their services – their core foc

4 inbound links article en big-techhypebusiness-models CC BY-SA 4.0
All Go: Methods and Interfaces

Having looked at the basic semantics of Go in the previous article, I’m continuing my exploration by looking at Go’s facilities for object orientation. This looks at structures and embedding in more detail, as well as methods and interfaces.

0 inbound links article en Software Andy Pearceblogsoftwarepythongopolymorphism
Compartmentalized Vibe Coding

Can we tame AI-generated code? Discover how API-centric architecture and prompt engineering provide perfect guardrails for agentic vibe coding.

Generative AI Hype Peaking

I have been a skeptic of some of the more breathless claims made for Generative AI since at least October 2023, when I participated in a panel organized by S...

0 inbound links article en
Scala's Future

On programming and personal projects

0 inbound links article en ScalaScala 3ProgrammingSnippetLanguagesProgramming RantTypeScript